Prostate Cancer Biomarker

The results, published in the Public Library of Science (PLoS) ONE journal, showed that MSMB is found at significantly lower levels in the urine of men diagnosed with prostate cancer than those without the disease. They also showed men with aggressive tumors were also likely to have lower levels of the protein in their urine.

Protein urine test may signal prostate cancer | Reuters

Lehman’s Journal Review 10.4.2010

BMJ Group blogs: BMJ » Blog Archive » Richard Lehman’s journal review, 4 October 2010

Like about 40% of adults of my age in Western countries, I have a fatty liver, though I don’t qualify for having nonalcoholic fatty liver disease because I drink too much. If I wanted to know what is really happening to my liver I would have to have serial biopsies, as would several million people in the UK. This non-disease correlates with a number of other non-diseases such as asymptomatic reduced left systolic ejection fraction and pre-diabetes, and some real risk factors such as actual diabetes and high blood pressure. So I might die of vascular disease; or liver failure if I really overdo the wine; or else from cancer or general crumble or whatever else awaits me and everyone else. This paper on the risk of cardiovascular disease in patients with nonalcoholic fatty liver disease goes through the data and leaves me none the wiser: and by the way, these people are not patients and they don’t have a disease.

 

General crumble?

Hypoglycemia in DM2 = Higher Mortality Risk

Medical News: Hypoglycemia a Marker of Poor Diabetes Outcomes – in Endocrinology, Diabetes from MedPage Today

Type 2 diabetes patients who experienced these serious drops in blood glucose had nearly three times the risk of death and twice the risk of a major macrovascular event compared with those who didn’t experience hypoglycemia, Sophia Zoungas, MD, PhD, of the University of Sydney in Australia, and colleagues reported in the New England Journal of Medicine.

Memantine for PDD or DLB

Underwriting Quick Notes:

  • PDD = Parkinson’s Disease Dementia
  • DLB = Dementia with Lewy Bodies
  • Memantine = Namenda

Memantine for patients with Parkinson’s disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial : The Lancet Neurology

Memantine seems to improve global clinical status and behavioural symptoms of patients with mild to moderate DLB, and might be an option for treatment of these patients.

Emphysema on CT Significantly Correlated With Mortality

Click through for the abstract.  There is a link on the page for a PDF version.

CT Scan Findings of Emphysema Predict Mortality in COPD — CHEST

Results: Of the 251 patients, 79 died, with 40 classified as respiratory deaths not involving lung cancer. Univariate Cox analysis revealed that emphysematous change as assessed by CT scan, lung function, age, or BMI were significantly correlated with mortality. Multivariate analysis revealed that emphysematous change as assessed by CT scan had the best association with mortality.

Conclusions: Emphysematous change as assessed by CT scan predicts respiratory mortality in outpatients with various stages of COPD.